156 related articles for article (PubMed ID: 38653955)
1. Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy.
Pérez A; Montoro J; Chorão P; Gómez D; Guerreiro M; Giménez E; Villalba M; Sanz J; Hernani R; Hernández-Boluda JC; Lorenzo I; Navarro D; Solano C; Ljungman P; Piñana JL
Infection; 2024 Apr; ():. PubMed ID: 38653955
[TBL] [Abstract][Full Text] [Related]
2. Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease.
Pérez A; Gómez D; Montoro J; Chorão P; Hernani R; Guerreiro M; Villalba M; Albert E; Carbonell-Asins JA; Hernández-Boluda JC; Navarro D; Solano C; Piñana JL
Bone Marrow Transplant; 2024 May; ():. PubMed ID: 38730040
[TBL] [Abstract][Full Text] [Related]
3. A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.
Piñana JL; Hernández-Boluda JC; Calabuig M; Ballester I; Marín M; Madrid S; Teruel A; Terol MJ; Navarro D; Solano C
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28544152
[TBL] [Abstract][Full Text] [Related]
4. Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation.
Piñana JL; Tridello G; Xhaard A; Wendel L; Montoro J; Vazquez L; Heras I; Ljungman P; Mikulska M; Salmenniemi U; Perez A; Kröger N; Cornelissen J; Sala E; Martino R; Geurten C; Byrne J; Maertens J; Kerre T; Martin M; Pascual MJ; Yeshurun M; Finke J; Groll AH; Shaw PJ; Blijlevens N; Arcese W; Ganser A; Suarez-Lledo M; Alzahrani M; Choi G; Forcade E; Paviglianiti A; Solano C; Wachowiak J; Zuckerman T; Bader P; Clausen J; Mayer J; Schroyens W; Metafuni E; Knelange N; Averbuch D; de la Camara R
J Infect Dis; 2024 Jan; 229(1):83-94. PubMed ID: 37440459
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Parainfluenza Virus Lower Respiratory Tract Disease after Hematopoietic Cell Transplantation.
Seo S; Xie H; Leisenring WM; Kuypers JM; Sahoo FT; Goyal S; Kimball LE; Campbell AP; Jerome KR; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2019 Jan; 25(1):163-171. PubMed ID: 30149147
[TBL] [Abstract][Full Text] [Related]
6. Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients.
Piñana JL; Gómez MD; Montoro J; Lorenzo I; Pérez A; Giménez E; González-Barberá EM; Carretero C; Guerreiro M; Salavert M; Sanz G; Hernández-Boluda JC; Borrás R; Sanz J; Solano C; Navarro D
Transpl Infect Dis; 2019 Oct; 21(5):e13158. PubMed ID: 31402532
[TBL] [Abstract][Full Text] [Related]
7. Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.
Piñana JL; Gómez MD; Pérez A; Madrid S; Balaguer-Roselló A; Giménez E; Montoro J; González EM; Vinuesa V; Moles P; Hernández-Boluda JC; Salavert M; Calabuig M; Sanz G; Solano C; Sanz J; Navarro D
Transpl Infect Dis; 2018 Aug; 20(4):e12926. PubMed ID: 29809298
[TBL] [Abstract][Full Text] [Related]
8. Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation.
Pérez A; Montoro J; Hernani R; Lorenzo I; Hernández-Boluda JC; Giménez E; Gómez MD; Balaguer-Roselló A; Gonzalez-Barberá E; Guerreiro M; Aguilar C; Navarro D; Solano C; Sanz J; Piñana JL
Transpl Infect Dis; 2020 Aug; 22(4):e13301. PubMed ID: 32363665
[TBL] [Abstract][Full Text] [Related]
9. Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Piñana JL; Xhaard A; Tridello G; Passweg J; Kozijn A; Polverelli N; Heras I; Perez A; Sanz J; Berghuis D; Vázquez L; Suárez-Lledó M; Itäla-Remes M; Ozcelik T; Iturrate Basarán I; Karakukcu M; Al Zahrani M; Choi G; Cuesta Casas MA; Batlle Massana M; Viviana A; Blijlevens N; Ganser A; Kuskonmaz B; Labussière-Wallet H; Shaw PJ; Yegin ZA; González-Vicent M; Rocha V; Ferster A; Knelange N; Navarro D; Mikulska M; de la Camara R; Styczynski J
J Infect Dis; 2021 May; 223(9):1564-1575. PubMed ID: 32860509
[TBL] [Abstract][Full Text] [Related]
10. The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation.
Piñana J; Montoro J; Aznar C; Lorenzo I; Gómez MD; Guerreiro M; Carretero C; González-Barberá EM; Balaguer-Roselló A; Sanz R; Salavert M; Navarro D; Sanz MA; Sanz G; Sanz J
J Infect; 2020 Mar; 80(3):333-341. PubMed ID: 31972212
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
12. Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation.
Montoro J; Sanz J; Lorenzo I; Balaguer-Roselló A; Salavert M; Gómez MD; Guerreiro M; González Barberá EM; Aguado C; Tofán L; Sanz GF; Sanz MA; Piñana JL
Bone Marrow Transplant; 2020 Dec; 55(12):2261-2269. PubMed ID: 32415227
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection.
Shiraiwa S; Harada K; Onizuka M; Kawakami S; Hara R; Aoyama Y; Amaki J; Ogiya D; Suzuki R; Toyosaki M; Machida S; Omachi K; Kawada H; Ogawa Y; Ando K
J Infect Chemother; 2022 Sep; 28(9):1279-1285. PubMed ID: 35691863
[TBL] [Abstract][Full Text] [Related]
14. The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey.
Piñana JL; Pérez A; Montoro J; Hernani R; Lorenzo I; Giménez E; Gómez MD; Guerreiro M; González-Barberá EM; Carretero C; Salavert M; Balaguer-Roselló A; Sanz G; Hernández-Boluda JC; Solano C; Sanz J; Navarro D
Bone Marrow Transplant; 2020 Feb; 55(2):431-440. PubMed ID: 31551521
[TBL] [Abstract][Full Text] [Related]
15. Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome.
Seo S; Xie H; Campbell AP; Kuypers JM; Leisenring WM; Englund JA; Boeckh M
Clin Infect Dis; 2014 May; 58(10):1357-68. PubMed ID: 24599766
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients.
Ogimi C; Krantz EM; Golob JL; Waghmare A; Liu C; Leisenring WM; Woodard CR; Marquis S; Kuypers JM; Jerome KR; Pergam SA; Fredricks DN; Sorror ML; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2293-2301. PubMed ID: 29777867
[TBL] [Abstract][Full Text] [Related]
17. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
Shah DP; Ghantoji SS; Shah JN; El Taoum KK; Jiang Y; Popat U; Hosing C; Rondon G; Tarrand JJ; Champlin RE; Chemaly RF
J Antimicrob Chemother; 2013 Aug; 68(8):1872-80. PubMed ID: 23572228
[TBL] [Abstract][Full Text] [Related]
18. Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study.
Piñana JL; Pérez A; Montoro J; Giménez E; Gómez MD; Lorenzo I; Madrid S; González EM; Vinuesa V; Hernández-Boluda JC; Salavert M; Sanz G; Solano C; Sanz J; Navarro D
Clin Infect Dis; 2019 May; 68(11):1894-1903. PubMed ID: 30239624
[TBL] [Abstract][Full Text] [Related]
19. Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time.
Ustun C; Slabý J; Shanley RM; Vydra J; Smith AR; Wagner JE; Weisdorf DJ; Young JA
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1580-8. PubMed ID: 22531491
[TBL] [Abstract][Full Text] [Related]
20. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
Nichols WG; Corey L; Gooley T; Davis C; Boeckh M
Blood; 2001 Aug; 98(3):573-8. PubMed ID: 11468152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
